A pharmaceutical company wanted to better monitor its sector. Because the industry is private in nature, the best place to gain insights is at industry events, but did not have the necessary resources to attend every industry conference and the corresponding sessions.
The Cell and Gene Therapy (CGT) Area has gained traction in recent years. A majority of big pharma has CGT assets in their pipeline. While it has a strong pipeline, the area witnessed a continued flow of investment. In our latest industry report on Cell and Gene Therapy Sector Performance and Outlook, we discuss how and why we believe that the CGT area has a lot to offer and except to see continued growth.
Evalueserve implemented a continuous monitoring program for a global healthcare company that wanted to monitor its competitors, the latest technologies, and IP developments in the healthcare domain.
Deal making in the global healthcare industry has been relatively slow in 2022, compared with a blockbuster 2021. Investors were primarily forced to hold off on deal making because of the uncertainty regarding the global growth outlook.
A MedTech pioneer, being a giant in the medical devices industry, needed to monitor a pool of therapeutic areas. They needed a singular centralized solution to get all insights, which they could then distribute internally to the respective stakeholders.
After successfully serving a leading global medical device company in different segments to stay abreast of their close competitors through extensive competitive (CI) monitoring, Evalueserve was internally recommended to their orthopedic department to conduct customized competitive intelligence programs in the orthopedic space on Insightsfirst.
A multinational healthcare giant had issues with its existing competitive intelligence program, so Evalueserve implemented our Insightsfirst platform for them.
Digital healthcare gained great prominence following the outbreak of COVID-19, as patients wanted to feel more empowered than ever before. Many venture funds stepped up to fund advanced digital health technology companies that were focused on AI-based data-driven connected technologies.
The post-conference report curated by Evalueserve mirrors the most impactful findings from lung cancer, breast cancer and acute myeloid leukemia in 2022.
With more novel drugs being launched and approved, pharmaceutical new product launch strategies need to evolve.
The COVID-19 pandemic has made the healthcare ecosystem and engagement for launch effectiveness more complex owing to the evolving needs of pharma stakeholders.
The ICER has backed bluebird bio’s revolutionary Zynteglo therapy for beta thalassaemia as cost-effective in their draft report. Will FDA’s additional back-to-back endorsement of Zynteglo and eli-cel pave the way for bluebird’s recovery, despite multiple misfires and dwindling finances?
AI can be found throughout clinics and hospitals working alongside doctors, nurses, and specialists. Automated systems help flag risk factors, identify likely conditions, and assist medical professionals with other vital forms of diagnoses and treatment. Our resident brand journalist Leah Moore spoke to our in-house AI expert Cathy Feng to learn more about the state of AI in the medical field.
It has been almost two years since the outbreak of COVID-19, but the pandemic still rages on. Vaccine rollout and policy support have continued to witness divergence across regions. The consistent and equitable implementation of tools to control the pandemic continues to be a challenge for governments across the globe.
Global Healthcare Market – 2021 It’s been over 16 months since the start of the pandemic, and we are still fighting
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
An international implementing agency is providing technical support to the government of India’s Ministry of Health and Family Welfare (MoHFW) country-wide Rotavirus Vaccination Immunization (RVVI) program.
Q&A with Sid Shivam, Associate VP for Life Sciences and Healthcare.
The COVID-19 pandemic has pushed the world in an economic recession that far worse than the financial crisis in 2008–09. Although many economies have been able to sail through the economic uncertainties, the fatigue induced by the pandemic is creating a new set of problems for governments across the globe.
The shock of the COVID-19 pandemic, and the lockdown measures adopted to contain it, have had a debilitating effect on the global economy. According to the World Bank, the global economy will likely contract by 5.2% in 2020.
The question we must address now is: “How do we interpret claim language?”
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Globally, we expect to see some clear logistics and demand disruption for the pharmaceutical industry overall, but relatively far less than is likely to be seen in most other industries/sectors. North America and EMEA are expected to invest significantly in API facilities to reduce their dependency on APAC.
Innovative R&D depends on combined technological, regulatory and IP insights, but how best to find relevant answers? We’ll help you navigate the vast amount of available scientific literature and patents so that you remain innovative, competitive and compliant.
These blog posts explained the key parameters that searchers need to consider to ensure an effective FTO search.
We asked 260 procurement professionals, in 14 industries worldwide, about the problems and priorities they face. Our findings, summarized in this exclusive survey report, feature the four key trends shaping the procurement landscape today.
Cognitive technology is the next big cost saving initiative in the world of procurement. We have taken a look at various cognitive solutions that are being implemented across industries and how they constructively evolve the overall maturity of the procurement organizations. The infographic below details these industries we have covered and their specific applications
Cognitive technology is transforming the way firms do business. In this article we explore how forward-looking companies around the world are putting cognitive technology to work across a range of business functions.
One of our clients invited our chief strategist to help them assess the proposal they had received from a prominent AI tool. See why he believes AI providers are not spending enough time on the analytics value chain before pitching their services.
Maintaining the headcount and in-house expertise to deal with the full range of IP administration tasks is costly. Our highly trained paralegals and specialists in patent drafting and prosecution are prepared to cover your needs. We can also support you with the business-critical transition from transactional to strategic IP management.
Using dedicated tools and models, our experts will help you gain deeper insights about your competitors, prospects and target industries.
Aware of the potential of social media as a source of marketing, strategy, and adverse event information, a major pharmaceutical company wanted to invest in AOL.
Data & Analytics
Data Engineering & Cloud
Customer Insights
Competitive & Market Intelligence
Marketing & Sales Enablement
Strategy & Planning
Supply Chain
R&D & Innovation
Intellectual Property
Pricing
ESG
Lending Services
Investment Banking Advisory
Financial Risk
Nonfinancial Risk
Investment Research
+ View All Solutions
Financial Institutions
Investment Banks
Corporate & Commercial Banks
Asset & Wealth Management Firms
Private Equity & Venture Capital Firms
Corporates
Technology & Telecom
Life Science & Healthcare
Manufacturing & Industrial Goods
Energy
Chemicals
CPG & Retail
Logistics & Transportation
Development Sector Practice
Professional Services Firms
Consultancy & Advisory Firms
Legal Firms
Real Estate Firms
Education & EdTech Firms
© 2022 Evalueserve. All rights reserved.
